Patents by Inventor Raphael Pappo

Raphael Pappo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4029689
    Abstract: The above-captioned compounds display anti-microbial activity, e.g. anti-bacterial and anti-fungal, and are, in addition, useful as intermediates in the manufacture of prostanoic acid derivatives.
    Type: Grant
    Filed: March 21, 1975
    Date of Patent: June 14, 1977
    Assignee: G. D. Searle & Co.
    Inventors: Mildred S. Bruhn, Raphael Pappo
  • Patent number: 4012391
    Abstract: 11.beta.-Alkyl-2-azaestratrienes, displaying valuable pharmacological properties, e.g. anti-viral and hypolipemic, are manufactured by a total synthesis originating with dihydroresorcinol.
    Type: Grant
    Filed: January 22, 1975
    Date of Patent: March 15, 1977
    Assignee: G. D. Searle & Co.
    Inventors: Robert J. Chorvat, Raphael Pappo
  • Patent number: 4007194
    Abstract: 2-Azasteroids, displaying valuable pharmacological properties, e.g. anti-viral, are manufactured by a total synthesis originating with dihydroresorcinol.
    Type: Grant
    Filed: May 6, 1974
    Date of Patent: February 8, 1977
    Assignee: G. D. Searle & Co.
    Inventors: Robert J. Chorvat, Raphael Pappo
  • Patent number: 4003996
    Abstract: The administration of aldosterone inhibitors of the spirolactone structural type prior to and during treatment with anti-neoplastic agents such as adriamycin results in retention of the desired activity of the latter substances while inhibiting their undesirable cardiotoxic properties.
    Type: Grant
    Filed: September 9, 1974
    Date of Patent: January 18, 1977
    Assignee: G. D. Searle & Co.
    Inventors: Raphael Pappo, Rothwell Polk
  • Patent number: 3991061
    Abstract: The present invention encompasses compounds of the formula ##SPC1##Wherein R represents hydrogen or lower alkyl having 1-7 carbon atoms and wherein one X represents (nitrogen) N and the other X represents methylidyne. The compounds of the present invention are prepared by the methods set out in the following scheme: ##SPC2##Wherein R and X are as defined above. Compounds of the present invention are useful anti-inflammatory agents.
    Type: Grant
    Filed: July 16, 1975
    Date of Patent: November 9, 1976
    Assignee: G. D. Searle & Co.
    Inventors: Robert J. Chorvat, Raphael Pappo
  • Patent number: 3970683
    Abstract: 3-(Optionally oxygenated)-5-oxocyclopent-1-enealkanoic acids and their alkyl esters are allowed to react with appropriate alkenyl copper, alkenyl boron, alkynyl boron, alkynyl gallium or alkynyl aluminum compounds to produce the corresponding 2-(3-hydroxy-3-[optionally alkylated]-1-alkenyl)cyclopentanealkanoic acids, 2-(3-hydroxy-3-[optionally alkylated]-1-alkynyl)cyclopentanealkanoic acids and their esters. The prostaglandin derivatives so produced are valuable and useful as pharmacological agents as is evidenced by their central nervous system-affective, anti-bacterial, anti-fungal and prostaglandin antagonist activity.
    Type: Grant
    Filed: November 12, 1974
    Date of Patent: July 20, 1976
    Assignee: G. D. Searle & Co.
    Inventors: Paul W. Collins, Raphael Pappo
  • Patent number: 3969391
    Abstract: 2-Alkoxy-4-hydroxy-5-oxocyclopent-1-eneheptanoic acid and its lower alkyl esters are reduced with metallic hydrides to yield the corresponding 3-hydroxy-5-oxo-cyclopent-1-eneheptanoic acid and its esters. The latter compounds are valuable intermediates in the preparation of pharmacologically active prostaglandin derivatives.
    Type: Grant
    Filed: May 8, 1974
    Date of Patent: July 13, 1976
    Assignee: G. D. Searle & Co.
    Inventors: Raphael Pappo, Christopher Jung
  • Patent number: 3965143
    Abstract: 16-Oxygenated prostanoic acid derivatives, displaying valuable pharmacological properties, e.g. gastric anti-secretory, are produced by reaction of an (optionally 3-oxygenated)-5-oxocyclopent-1-enealkanoic/alkenoic acid or ester with the appropriate organometallic reagent.
    Type: Grant
    Filed: March 26, 1974
    Date of Patent: June 22, 1976
    Assignee: G. D. Searle & Co.
    Inventors: Paul W. Collins, Raphael Pappo
  • Patent number: 3962291
    Abstract: A novel total synthesis of 11-alkyl steroids, utilizing readily available and inexpensive raw materials, is described. The resulting products are useful and novel pharmacological agents possessing, for example, selective hormonal properties.
    Type: Grant
    Filed: September 5, 1974
    Date of Patent: June 8, 1976
    Assignee: G. D. Searle & Co.
    Inventors: Robert B. Garland, Raphael Pappo
  • Patent number: 3932496
    Abstract: Novel mono- and dialkylated prostynoic acid derivatives, prepared by condensation of a suitably substituted cyclopentene carboxylic acid or ester with a suitable organometallic alkynyl derivative, display valuable pharmacological properties. For example, they are potent inhibitors of gastric secretion.
    Type: Grant
    Filed: April 23, 1973
    Date of Patent: January 13, 1976
    Assignee: G. D. Searle & Co.
    Inventors: Christopher Jung, Raphael Pappo